TY - JOUR
T1 - Common and Rare Ocular Side-effects of the Dexamethasone Implant
AU - Fassbender Adeniran, Janelle M.
AU - Jusufbegovic, Denis
AU - Schaal, Shlomit
N1 - Publisher Copyright:
© Taylor & Francis Group, LLC.
PY - 2017/11/2
Y1 - 2017/11/2
N2 - Purpose: Expanding indications for use, and overall increased use of the slow–release dexamethasone (DEX) implant yields an opportunity to study the reported ocular side–effects and adverse events associated with this drug. Methods: A PubMed.gov (US National Library of Medicine, National Institutes of Health) review of literature for the search terms, “Ozurdex and complication,” through December 2015. Results: Ocular hypertension and cataract are the main long-term sequelae identified in large, randomized clinical trials. Case reports have emerged regarding implant migration, complications with implantation, infection, and posterior segment sequelae, including vitreomacular traction. Conclusion: DEX implant overall is well–tolerated and, with careful monitoring, can be a useful adjunct to treating macular edema associated with diabetes, retinal vein occlusion, and chronic uveitis.
AB - Purpose: Expanding indications for use, and overall increased use of the slow–release dexamethasone (DEX) implant yields an opportunity to study the reported ocular side–effects and adverse events associated with this drug. Methods: A PubMed.gov (US National Library of Medicine, National Institutes of Health) review of literature for the search terms, “Ozurdex and complication,” through December 2015. Results: Ocular hypertension and cataract are the main long-term sequelae identified in large, randomized clinical trials. Case reports have emerged regarding implant migration, complications with implantation, infection, and posterior segment sequelae, including vitreomacular traction. Conclusion: DEX implant overall is well–tolerated and, with careful monitoring, can be a useful adjunct to treating macular edema associated with diabetes, retinal vein occlusion, and chronic uveitis.
KW - Cystoid macular edema
KW - dexamethasone
KW - Ozurdex
KW - retinal vein occlusion
KW - side-effects
KW - uveitis
UR - http://www.scopus.com/inward/record.url?scp=84979057689&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84979057689&partnerID=8YFLogxK
U2 - 10.1080/09273948.2016.1184284
DO - 10.1080/09273948.2016.1184284
M3 - Review article
C2 - 27379861
AN - SCOPUS:84979057689
VL - 25
SP - 834
EP - 840
JO - Ocular Immunology and Inflammation
JF - Ocular Immunology and Inflammation
SN - 0927-3948
IS - 6
ER -